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ABSTRACT: γ-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the
central nervous system (CNS). Dysfunctional GABAergic neurotransmission is associated
with numerous neurological and neuropsychiatric disorders. The GABAB receptor (GABAB-
R) is a heterodimeric class C G protein-coupled receptor (GPCR) comprised of GABAB1a/b
and GABAB2 subunits. The orthosteric binding site for GABA is located in the extracellular
Venus flytrap (VFT) domain of the GABAB1a/b. Knowledge about molecular mechanisms
and druggable receptor conformations associated with activation is highly important to
understand the receptor function and for rational drug design. Currently, the conformational
changes of the receptor upon activation are not well described. On the basis of other class C
members, the VFT is proposed to fluctuate between an open/inactive and closed/active
state and one of these conformations is stabilized upon ligand binding. In the present study,
we investigated the dynamics of the GABAB1b-R VFT in the apo form by combining unbiased molecular dynamics with path-
metadynamics. Our simulations confirmed the open/inactive and closed/active state as the main conformations adopted by the
receptor. Sizeable energy barriers were found between stable minima, suggesting a relatively slow interconversion. Previously
undisclosed metastable states were also identified, which might hold potential for future drug discovery efforts.
■ INTRODUCTION
γ-Aminobutyric acid (GABA) is the most abundant inhibitory
neurotransmitter in the mammalian central nervous system
(CNS) and central in modulating neuronal activity. GABA
exerts its physiological effects through a distinct receptor
system consisting of the ionotropic GABAA and GABAC
receptors and the metabotropic GABAB receptor (GABAB-
R).1 Dysfunction in GABAergic and GABAB-R signaling is
linked to a broad variety of neurological and neuropsychiatric
disorders, including memory and learning deficits, addiction,
epilepsy, schizophrenia, anxiety, and depression.2−4 The
involvement of this receptor in human pathophysiology
makes it a valuable drug target. A better understanding of
the conformational dynamics associated with receptor
activation is beneficial for new drug discovery.
GABAB-R is an obligate heterodimeric receptor comprised
of GABAB1a/b and GABAB2 subunits. The receptor belongs to
class C of G-protein coupled receptors (GPCRs), together
with the metabotropic glutamate receptors (mGlu1-8-R), the
calcium-(CaSR), and sweet and umami taste receptors.5 Each
subunit consists of an extracellular Venus flytrap (VFT) linked
to a heptahelical transmembrane (7TM) domain (Figure 1),5
and hence GABAB-R does not contain the cysteine-rich linker
that has been shown to play an important role in transmitting
the activation signal from the VFT to the 7TM of other class C
GPCRs.5 Likewise, the disulfide bridge that cross-links the
VFT dimer of mGluRs is not present in the GABAB-R VFT.
5
Radioligand binding studies and site-directed mutagenesis
studies show that the orthosteric binding site of GABAB-R is
located in the VFT of GABAB1a/b, while binding of ligands to
the VFT of GABAB2 has not been observed.
6 The 7TM
domain of GABAB2 hosts an allosteric binding site and is
responsible for G-protein coupling.7,8 GABAB1a/b is dependent
on dimerization with GABAB2 for trafficking from the
endoplasmic reticulum (ER) to the cell surface as GABAB2
masks a retention signal present in the cytoplasmic tail of
GABAB1a/b.
9
Binding studies with recombinant receptor mutants, radio-
ligand binding, and displacement assays have shown that the
VFT of GABAB1a/b is functional in absence of the GABAB2
VFT, although with reduced agonist affinities.6,10−12
The three-dimensional (3D) structure of the entire GABAB-
R is not known; however, nine X-ray crystal structures of the
VFTs cocrystallized with different agonists, antagonists, and
one apo form have been published.13 The VFTs have a
bilobular architecture where the two lobes (Lobe 1 and Lobe
2) are separated by a cleft and come into close contact upon
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agonist binding (yielding the active/closed state), hence the
name VFT (Figure 1).13 Residues located in Lobe 1, such as
Trp65, Ser130, G151, Ser153, His170, and Glu349, are
responsible for anchoring ligands in the binding pocket and
interacts interchangeably with both agonists and antagonists.13
Ligand interaction with the Lobe 2 residue Tyr250 is unique
for agonists, and the Trp278 located in the same domain has
been found to only interact with high-affinity antagonists in
addition to agonists (Figure 1).13,14
The X-ray crystal structures of GABAB-R VFTs show that
the GABAB1a/b VFT is in a closed state in presence of agonists
(the active/closed state) and in an open state when complexed
with antagonists (the inactive/open state).13 However, mGluR
VFT X-ray structures show that agonists and antagonists can
both induce closed and open VFT conformations.15 Further,
single-molecule Förster resonance energy transfer (smFRET)
studies show that mGluRs in absence of ligand are in rapid
exchange in the sub-milli-second timescale between active and
inactive conformations, while binding of agonists is suggested
to rapidly shift the equilibrium toward the active/closed
state.16 The equilibrium between open and closed conforma-
tional states of mGluRs indicates that they are energetically
equal, independent of ligand presence.16 Despite high
sequence similarities between the eight mGluRs, kinetic
differences between the receptors are identified.17 Although
the sequence identity between the full mGluR2 and mGluR3 is
as high as 70%, it has been shown that the active state of
mGluR3 is more energetically stable than that of mGluR2 and
that mGluR3 can be activated by Ca2+, while mGluR2
cannot.17 The sequence similarity between the mGluRs and
GABAB-R VFTs is lower than between the mGluRs and is in
the range of 43−48%.18
The activation mechanism of GABAB-R is partly elusive and
mostly based on assumptions from knowledge regarding other
class C members. In the present study, we aimed to investigate
the structural dynamics of the GABAB1 VFT and describe the
behavior of the system in the absence of ligands. To save
computational time, only the monomeric form of the GABAB1b
VFT that contains the orthosteric site was considered as it has
been demonstrated by multiple binding studies that GABAB1b
is functional without the GABAB2 VFT present.
11,12 Six
microsecond-long molecular dynamics (MD) simulations,
using both the inactive/open and closed/active states of the
GABAB1b VFT as starting structures, were run to explore the
functional dynamics of the receptor. The pool of trajectories
obtained was instrumental to derive a suitable reaction
coordinate that was exploited to guide the conformational
transition through path-based enhanced sampling simula-
tions.19
Enhanced sampling methods are well-accepted MD-based
approaches suited for accelerating the occurrence of rare
events and estimate the associated free energy surface (FES).20
A method that can be used is metadynamics,20 where a history-
dependent biasing potential is added to selected degrees of
freedom (also called collective variables (CVs)) to encourage
the system to visit higher energy states. For the procedure to
Figure 1. Schematic illustration of the GABAB-R. The heterodimeric GABAB-R is comprised of GABAB1a/b (gray) and GABAB2 (black) (A). The
7TM domains are located in the membrane (yellow) (A). The orthosteric binding site is located in the extracellular VFT of GABAB1a/b (B). Ligand
binding is facilitated by interactions with key residues such as Tyr250 and Trp278 located in Lobe 2, Gly151, His170, and Glu349 located in Lobe
1 (black box, PDB ID: 4MS3 in complex with GABA).
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be effective and the reconstructed FES, accurate, a limited
number of CVs must be able to fully characterize the process.
Unfortunately, for complex phenomena like protein conforma-
tional rearrangements, the identification of a proper set of CVs
is challenging20 and chemical intuition and/or trial and error
procedures are required to fulfill this aim. However, when the
start and endpoints of the transition and an educated guess of
the underlying mechanism are available (i.e., the path bridging
the end points), this step can be facilitated by using the so-
called path-CVs (PCVs) formalism. When properly para-
meterized, PCVs may provide an optimal description of a
transition process and in addition, PVCs also have the
possibility of being iteratively improved.21 PCVs have
successfully been used to study conformational transitions,22,23
ligand binding/unbinding,24−26 and ion conduction.27
In the present study, we use well-tempered metadynamics
(WT-MetaD)28 combined with PCVs to fully characterize
conformations underlying the transition between open and
closed GABAB1b VFT states. In particular, we show that open/
inactive and closed/active VFT states are almost iso-energetic
and separated by substantial energy barriers. Additionally,
along the conformational transition, we identified metastable
states that might play a significant role in the opening/closure
mechanism and can be further exploited to drive structure-
based drug discovery endeavors.
■ METHODS
Protein Preparation. X-ray crystal structures of GABAB1b
VFT in complex with antagonists (open/inactive state; PDB
IDs: 4MR7, 4MR8, 4MR8), the agonists GABA and baclofen
(closed/active state; PDB IDs: 4MS3, 4MS4, respectively),
and one in apo form (open/inactive state; PDB ID: 4MQE)
were selected for the study. The ligands and the GABAB2 VFT
were removed from each X-ray crystal structure, and the
remaining GABAB1 VFT structures were preprocessed in
Schrödinger Protein Preparation wizard using default settings
(hydrogens were added according to the physiological
protonation states at pH value of 7; bond orders were assigned
and disulfide bonds created).29 A minimization run was
performed with converging heavy atoms at root mean square
deviation (RMSD) of 0.3 Å.30
Unbiased Molecular Dynamic Simulations. For each of
the six processed GABAB1 VFT structures, a 1 μs long MD
simulation was performed using GROMACS 2016 MD
package31 and the AMBER99SB-ILDN force field.32 To set
up the individual systems, N-methyl amide (NME) and acetyl
(ACE) caps were added to the N- and C-termini, the protein
was solvated in a cubical box adopting the transferable
intermolecular potential 3P (TIP3P) water model,33 and the
total charge of each system was neutralized by adding three
Na+ ions. Energy minimization using the steepest descent
minimization algorithm was performed and run until the
maximum force of the system reached <1000 kJ/(mol·nm)
using GROMACS 2016 MD package.31
System equilibration was achieved by performing a 100 ps
MD simulation in the NVT ensemble followed by a 5 ns
constant number of atoms, pressure, and temperature (NPT)
equilibration, using the leap-frog integrator with a time step of
2 fs. The temperature was coupled to the stochastic v-rescale
modified Berendsen thermostat34 at the target temperature of
300 K with a time constant of 0.1 ps. In the isothermal−
isobaric ensemble, the pressure was controlled with the
Parinello−Rahman barostat35,36 with a coupling constant of
1 ps and a reference pressure of 1 bar. All bonds involving
hydrogen atoms were constrained with the LINCS algorithm.37
The Verlet cutoff scheme was used with short-range electro-
static and van der Waals cutoff at 14 Å. The long-range
electrostatic interactions were treated using the particle mesh
Ewald (PME) method with a 4th-order spline and Fourier
spacing of 1.6 Å. Following system equilibration, production
runs of 1 μs were performed as an extension of the previously
described NPT ensemble and by saving conformations every
10 ps.
MD simulations were monitored by calculating the root
mean square deviation (RMSD) and root mean square
fluctuation (RMSF) over Cα atoms using a closed/active
crystal structure as a reference (PDB ID: 4MS3). The RMSF
analysis showed that residues in Lobe 2 fluctuated less than
residues in the Lobe 1 and selected Cα atoms of this lobe were
therefore used in all subsequent structure alignments (see
Table S1 and Figure S1).
Optimization of the Path Variables. Transitions
between open/inactive and closed/active conformational states
of the GABAB1 VFT were characterized by well-tempered
metadynamics (WT-MetaD) and path collective variables
(PCVs). PCVs provide an optimal description of the process
under investigation provided that the end points of the
transition are known and that an educated guess of the
underlying mechanism is established. Specifically, with PCVs,
the path joining the end points is described by an ensemble of
intermediate structures in configurational space (x) that
represent the so-called frame set (i = 1, 2, ..., N). Then, the
progression along the path and the distance from it is evaluated
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In the definition of S and Z, λ is a tunable parameter
controlling the smoothness of the mapping from the discrete
frameset to the continuous space of the variables (see below).
The distance of the current configuration from all members of
the frameset is usually evaluated through the mean squared
displacement (MSD) calculated between a predefined subset
of atoms after optimal body superposition. Specifically, in eqs 1
and 2, R[x − xi] represents the MSD. The variables xi are the
Cartesian coordinates of the subset of Cα atoms belonging to
Lobe 1 employed to evaluate the conformational transition
after optimal alignment on the subset of atoms belonging to
Lobe 2 that is acting as a reference frame (see Table S1 and
Figure S1). Conversely, the x variables represent the current
configuration of Cα atoms belonging to Lobe 1 during the
metadynamics simulation. In this way, all sampled config-
urations are continuously and smoothly mapped onto the S
and Z space. In this work, both the end points and the
educated guess path used to parameterize PCVs were extracted
from the MD trajectories obtained by the previous step.
The end points corresponded to the equilibrated con-
formations obtained from PDB ID: 4MS3 and PDB ID: 4MQE
for the closed/active (i = 1) and open/inactive states (i = N),
respectively. Notably, while the equilibrated structure of the
closed/active state closely resembled the corresponding
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crystallographic geometry, the other end point represented a
conformational state of GABAB1 VFT with a greater separation
between the lobes as compared with the antagonist bound
structures and the apo form. This state (hereafter referred to as
“wide open”, see also Figure 3) could only be identified
through MD simulations and was intentionally employed as an
end point in the PCV parameterization to ensure that the
entire conformational transition was covered. The remaining
(N − 2) intermediate structures of the frame set were extracted
from the aggregated trajectories in an iterative fashion. Each
time a new guess path was generated, the size of the frameset
(N) and the interframe distance could change, and therefore
the value of λ needed to be modified accordingly. Here, λ was
adapted based on the average MSD calculated between
adjacent frames following the rule of thumb: λ = ln⟨|xi −
xi+1|
2⟩−1. The initial guess path was obtained through the
interpolation scheme implemented in the Climber program39
using the structural information of the end points only. In
contrast to other morphing tools, Climber does not interpolate
conformations linearly but instead uses the restraining energy
in a linear manner depending on the distance deviation
between the current and the reference structure.39 This
concept allows larger structural flexibility and permits the
protein to be sampled around high-energy barriers. Each
Climber step was followed by energy minimization of the
predicted structure.39 The number of intermediates was set to
a minimum of 150 minimized structures. Then, a total number
of 30 equispaced frames were extracted with an in-house script
and the λ value was set to 312 nm−2. In the S/Z framework, the
total number of frames (N) must be chosen as a compromise
between the accuracy of the mechanistic description (N large)
and the computational convenience (N low). In this work, we
tuned the frame set in a way to satisfy an average interframe
distance of about 0.86 Å. As the quality of this path was
evaluated to be a suboptimal representation of the true
mechanism of the conformational transition (Figure 2A), we
aimed to extract the guess path from the pool of available
trajectories. We then performed a cluster analysis using the
GROMACS clustering tool31 with an RMSD distance
calculated from the Cα atoms with a 1.5 Å cutoff. The
centroid conformation from each cluster was chosen as cluster
representatives with specific S and Z values (see Table 1). The
centroids corresponding to the most populated clusters (first
10 out of 35) were then selected and connected using
Climber.39
The optimized path was then obtained by concatenating all
disconnected partial paths obtained through Climber (for a
total number of 1045 minimized structures) and selecting an
ensemble of equispaced conformations in a way to obtain a
frame set with N = 40, λ = 193 nm−2, and an interframe
distance of 1.1 Å. Projection of the unbiased trajectories onto
the newly optimized PCV space showed that all sampled points
were now lying in the close proximity of Z = 0, indicating that
a satisfactory representation of the transition was obtained.
The schematic representation of the entire procedure is shown
in Figure 2. The refined path was then used as a collective
Figure 2. Overview of the main steps performed to obtain a path describing the conformation transition from the closed to the open state. (A)
unbiased-MD projection of trajectories onto the initial path, (B) cluster analysis for identification of physically meaningful intermediate structures,
(C) bridging the clusters to obtain the refined path, and (D) PCV validation through projection of the unbiased-MD trajectories onto the refined
path.
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variable in a WT-MetaD simulation using GROMACS 201631
patched with PLUMED.40 The temperature was set to 300 K
and Gaussian hills were added in a regular interval of 1 ps with
a height of 0.1 kcal/mol and the width of 0.2 for both variables,
S and Z. The bias factor used to rescale the Gaussian height in
the simulation was set to 8, and the total run length of the
simulation was 2 μs. The free energy was reconstructed at the
end of 2 μs of sampling and right after the main recrossing
event at about 1.2 μs (see Figure S2A). Since after the
recrossing event the system was found to be stuck in the
closed/active basin, to avoid overfilling, we consider the FES
obtained at 1.2 μs as the conclusive result of this simulation.
For the sake of comparison, the one-dimensional (1D)-free-
energy profiles and the 2D-FES obtained at the end of the 2 μs
sampling are shown in Figures S2B and S3, respectively.
A second cluster analysis of conformations sampled during
metadynamics was performed with emphasis on the key
residues in the binding pocket as previously described, with an
RMSD distance calculated from the heavy atoms of each
residue using 1.5 Å as a cutoff. The conformations sampled
only in three selected stationary points (selected in
correspondence with the S value) were selected.
All data and PLUMED input files required to reproduce the
results reported in this paper are available on PLUMEDNEST
(www.plumed-nest.org), the public repository of the PLUMED
consortium,41 as plumID:20.002.
Committor Analysis. The quality of the S variable in
describing the conformational transition was assessed through
a committor analysis.42 Specifically, this analysis quantifies the
commitment probability of trajectories initiated from a given
point in the CV space to reach one of the main metastable
states (in this context, usually referred to as state A and state
B). Here, state A (corresponding to the closed state) was
defined as the region spanned by S ≤ 11.5 and Z ≤ 0.05 nm2,
while state B (corresponding to the open state) was defined as
S ≥ 21.5 and Z ≤ 0.05 nm2. Hundred unbiased MD runs were
started in close proximity of the transition state at S = 16.5 and
Z = 0.05 nm2 and were automatically terminated once the A or
B state was reached through the PLUMED software.40
■ RESULTS
Unbiased MD Simulations. The Cα RMSD of each
trajectory (Figure S4) was calculated using an X-ray crystal
structure in the closed/active state (PDB ID: 4MS4) as a
reference structure. The results showed that the Cα RMSDs
from the unbiased MD simulations of GABAB1b VFT in the
closed/active state (PDB IDs: 4MS3 and 4MS4) diverged at
the beginning of the simulation (first 250 ns), but afterward
their RMSDs reached similar values, indicating an overlapping
conformational space for the rest of the simulation (Figure S4,
green plots). Cα RMSD plots obtained from the simulation of
GABAB1b VFT in inactive/open states (PDB IDs: 4MR7,
4MR8, 4MQE, and 4MQF) showed similar trends, except that
the RMSD of the apo structure (PDB ID: 4MQE) increased
considerably during the last part of the simulation (>850 ns,
Figure S4, dark blue plot), reflecting that the VFT at this stage
of the dynamics adopted a wide-open state. This behavior is
highlighted by the 2D-RMSD plot (Figure 3), where a clear
overlapping region of conformational states can be found, as
well as the wide-open conformation occasionally reached by
the simulations started from the apo structure. We note that
the same subset of atoms used in the definition of the S and Z
variables was used to obtain these plots.
Importantly, a complete conformational transition could not
be observed through this initial set of simulations. In spite of
this, the obtained pool of trajectories was sufficient to derive a
suitable reaction coordinate that was then exploited to guide
the conformational transition through path-based enhanced
sampling simulations.19
Metadynamics Simulations. To evaluate the dynamical
behavior of GABAB1b VFT domain, a guess path describing the
Table 1. Number of Conformations Found in the Most
Populated Clusters (Populations), and Corresponding
Cluster-IDsa
cluster-ID population S Z (Å2)
1 17 018 11.8 19.4
2 4960 2.6 3.2
3 3579 1 4.6
4 1140 8.6 6.6
5 1099 21.5 8.1
6 837 10.2 11.7
7 357 16.1 20.1
8 173 5.7 4.6
9 159 26.9 3.9
10 157 14.6 26.1
11 124 13.3 16.7
12 87 15.4 15
13 62 8 4.5
14 36 3 6.9
15 35 1 5
16 29 11.6 7.6
17 26 7.5 7.6
18 26 13.9 41.5
19 21 12.8 15.1
20 15 4.8 14.1
aCluster centroids were selected, and S and Z values of these
conformations were calculated (last two columns). Only the most
populated clusters are shown.
Figure 3. Projection of the six 1 μs long trajectories onto the two-
dimensional (2D)-RMSD space. The profile is calculated using PDB
ID 4MS4 and 4MQE as references for the closed and open states,
respectively. The entire set of data points is shown as gray dots and
the projection of individual trajectories are plotted with a greater
stride. The color code is consistent with the legend inside the plot and
used throughout this work (green for the closed state and blue for the
open state).
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transition of the VFT from the active/closed to inactive/open
state was optimized using the information coming from the six
1 μs long trajectories of unbiased MD simulations. The initial
path was generated by using the Climber morphing tool.39
Evaluation of this path by projecting the six MD trajectories on
the space spanned by PCVs (Figure 2A) showed that most of
the points representing individual configurations sampled by
unbiased MD were far away from the guess path, ideally
located at Z = 0 for all values of S. This indicated that the
initial path was a poor representation of the conformational
transition mechanism. Despite no full conformational tran-
sition obtained, the individual trajectories were partly over-
lapping in the PCV space (Figure 3) and we therefore aimed to
exploit the information in the pool of trajectories to refine the
path and possibly obtain a more trustworthy representation of
the mechanism. By selecting conformations from the MD
clusters, we ensured that the new path not only covered the
whole transition but also retained salient features of the
mechanism as captured by the most populated conformations
sampled along the pathway. The projection of the MD
trajectories on the new PCV space showed low Z (<3 Å2)
values, indicating that the final obtained path was a reliable
representation of the transition (Figure 2D).
The FES obtained after 1.2 μs of metadynamics simulations
showed a local minimum in the first frames of the path,
corresponding to the closed (active) conformation (basins I
and II, Figure 4A). A second broad minimum covering the
frames close to the intermediate part of the path corresponded
to the inactive (open) conformation (basins V and VI, Figure
4A). These two regions were almost iso-energetic with a slight
preference toward the open state and were separated by energy
barriers of approximately 16 kcal/mol. The committor analysis
showed that the S variable was reasonably well-suited to
describe the transition under investigation, especially consid-
ering the complexity of the domain motion and the number of
atoms involved. Starting a series of unbiased MD simulations
nearby the transition state gave an estimated probability to
reach the open conformation of 0.31 (Figure S5). The
orientation of amino acids involved in the binding of agonists
and antagonists in X-ray crystal structures was compared to
their orientation obtained from metadynamics simulations
(Figure 4B). Cluster analysis performed for the two main
metastable states (II and VI) gave insight into conformational
changes of the binding site amino acids along the transition. In
particular, the conformational changes of Trp278 and Tyr250
relative to the X-ray complexes were analyzed in detail. In the
second main metastable basin corresponding to the stable
closed conformation (basin II, Figure 4A), Trp278 showed a
slight outward rotation compared with the crystal structures
cocrystallized with the agonist GABA and the agonist baclofen
Figure 4. Closed-to-open conformational transition of the GABAB1b VFT domain. (A) FES obtained from 1.2 μs long metadynamics simulation as
a function of the S and Z variables. The contours are plotted every 2 kcal/mol. The bottom panel (B) shows the orientation of the key residues
implicated in ligand binding. Pastel green and cyan residues represent the X-ray crystal conformations of the binding site in the closed and open
state, respectively, whereas the dark green and blue residues represent the adopted conformation of the same residues in three major minima (I, II,
VI). The two main clusters of each minimum are reported (#1, #2).
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(#1 in Figure 4B). Also, Tyr250 adopted a different orientation
(outward rotation) compared with the crystal structures in
complex with agonists. The rotation of Tyr250 was also seen in
other metastable states (basin III, Figure 4A) that
corresponded to intermediate conformations observed during
the closed-to-open movement. Analyzing the same residues in
basin VI, corresponding to the open state (Figure 4A, basin
VI), we notice that Trp278 goes through a rotational
movement causing the residue to occupy the same space as
seen in the inactive/open X-ray crystal structure (#1, Figure
4B), while Tyr250 rotated back to the original orientation
observed in the active/closed X-ray structures (#1, Figure 4B).
Other residues playing key roles in ligand binding (His70,
Gly151, Ser153, Ser130, and Ser131) maintained their
geometry during the simulation, showing high structural
stability even in the absence of ligands. Glu349 represented
the only exception to this behavior, possibly due to the absence
of a positively charged counterpart.
■ DISCUSSION
In the present study, the conformational dynamics of the
GABAB1 VFT was studied through MD simulations initiated
from six distinct X-ray crystal structures of the GABAB1 VFT.
Four of the selected structures represented the inactive/open
conformation, while two VFT represented the active/closed
state. On the basis of the sampled conformations, a path was
generated describing the full transition from the closed to the
open conformation. The path was then used as a CV in a
subsequent metadynamics simulation to resample the con-
formational movement and estimate the associated FES.
Many biologically important events such as protein−protein
interactions and large domain motion occur in the millisecond
(ms) to second timescale and major conformations are often
separated by high energy barriers.43 In spite of recent
improvements in hardware and software,44 interesting
conformational events of macromolecules are still inaccessible
for unbiased sampling methods due to the limitation of the
timescales (>ms). For example, the rearrangements of the
transmembrane domain of mGluR1 during receptor activation
are in the 20 ms timescale.45
The analysis performed on the aggregated trajectory
obtained from the six unbiased MD simulations showed that
a viable reaction coordinate could be extracted to fully describe
the conformational transition of the GABAB1 VFT, even
though individual trajectories spanned only a limited portion of
the conformational space. The analysis also showed that one
crystal structure initially in an inactive/open conformation
(PDB ID: 4MQE), sampled a previously undescribed wide-
open state during the last part of the simulation. This might be
a conformation less frequently accessed by the receptor, even
though we cannot rule out that the absence of the GABAB2
VFT might have exacerbated this behavior. Future inves-
tigations are needed to clarify this aspect. However, we
included this conformation as an endpoint of our optimized
path to ensure that the entire transition could be sampled
during the following metadynamics simulation.
Metadynamics is a powerful technique for accelerating rare
events and reconstructing the free energy associated with
selected movements such as conformational changes and
binding of ligands.20,24,27 With metadynamics, the sampling is
accelerated by adding a bias potential to a few CVs describing
the event one aims to investigate. This allows the system under
investigation to efficiently cross energy barriers and thereby
explore “infrequent events” that are only occasionally observed
or even inaccessible by conventional MD simulations.46
Specifically, in a metadynamics simulation, a history-dependent
bias potential is added as a sum of Gaussians deposited at a
regular time along the CV space.46 As Gaussians are deposited,
the underlying bias potential grows and encourages the system
to explore new regions of the CV space by crossing saddle
points and thus reaching previously unexplored low-energy
basins. Additionally, the bias potential can be used to estimate
the underlying free energy as a function of the CVs.46
Identification of reliable CV depends on knowledge of the
target under investigation and is very important for the
reliability of the simulation. Among popular CVs, atomic
distances, dihedrals, angles, and atomic contacts can be
mentioned.20 Selecting appropriate CVs is highly challenging
as macromolecules have a huge number of degrees of freedom
and topological complexity. A CV must describe the slow
motion of the system, if this motion is relevant for the process
under investigation.20 Also, the chosen CV should be able to
distinguish between the initial and final states, including
relevant intermediates.46 As an example, Branduardi et al.
applied metadynamics to describe the translocation of
tetramethylammonium (TMA) in the acetylcholinesterase
(AChE) gorge using the distance between the TMA and
AChE as a single CV.47 The results showed that an important
slow motion was neglected, resulting in a fluctuating behavior
and preventing a proper convergence of the FES.47 An
aromatic residue was blocking the gorge, and additional CVs
describing this rare event was necessary for obtaining the
correct FES.47 To avoid such a trial and error procedure, we
adopted a path-CV formalism. PCVs are flexible descriptors
allowing competition of the progression along a user-defined
path and the distance from it, thereby reducing the problem of
finding a limited number of correct CVs for describing a
complex movement. The equilibrated state corresponding to
the active/closed state was selected as the initial structure for
the path, while the endpoint was represented by the wide-open
conformation sampled in the unbiased MD simulation.
Conversely, the intermediate frames consisted of an ensemble
of conformations generated from interpolation and extraction
from the pool of trajectories obtained through unbiased MD
(see the Methods section). We acknowledge that more elegant
solutions based on Markov State Models are currently available
to extract reaction coordinates from previous MD simula-
tions.26,48 However, these approaches require much more
thorough sampling than what could be achieved in the present
work. Moreover, we note that during metadynamics, the
system is allowed to explore regions in configurational space
significantly distant from the input path. From this standpoint,
PCVs should be regarded as a nonlocal reaction coordinate.
The X-ray crystal structures are assumed to be in a low-
energy conformation and should therefore correspond to two
local minima on a FES. The FES obtained by using our path
showed local energy minima at values of the S variable
corresponding to the closed/active X-ray structure (basins I
and II in Figure 2A) and the open/inactive receptor
conformation (basins V and VI), with equivalent low Z values
and similar energy. These major conformational states turned
out to be separated by substantial energy barriers. Other
metastable states were observed at relatively high-energy
regions of the PCV space (basins III and IV in Figure 2A).
We suggest that these intermediate conformations are
effectively populated only upon ligand binding. The wide-
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open state was also included in definition of the optimized path
to probe its stability. Despite this conformation being actually
sampled during metadynamics, the less favorable energetics
supports the theory that this conformation is only occasionally
visited.
The energy barrier separating the two local minima
corresponding to the open and closed states was estimated
to be in the order of 16 kcal/mol. The height of this barrier
also supports that GABAB1 VFT requires an agonist to undergo
efficient receptor closure, unlike mGluRs that oscillate between
the two states independent of ligand binding as described by
Olofsson et al. and Grushevskyi et al. using mGluR2 and
mGluR1, respectively.16,45 The analysis of the key residues
participating in ligand binding showed that the geometry was
unchanged for most of the residues during the simulation, also
supporting the need for an agonist to induce conformational
changes. We wish to underline that none of these residues were
directly influenced by the simulation bias, which only has the
purpose of accelerating the domain motion between the open
and closed states.
It is important to be aware of possible methodological
limitations that might have played a role in determining the
high energetic barrier recorded. We note that some of these
limitations are related to widely accepted simulative setups,
while others are more specifically inherent to the current
investigation. As previously mentioned, for computational
convenience, only the monomeric form of the GABAB1b VFT
was considered in the simulations. Although experimental
studies show that the monomer is functional with lower
agonist affinity in the absence of GABAB2 VFT
11,12 and that
the conformation of GABAB2 is nearly independent of the
presence of GABAB1a/b,
13 we cannot rule out that potential
dimeric cooperative effects might be neglected in our
simulations. From this standpoint, the simulations presented
in this work can be regarded as a control for future
investigations on the energetics of the dimer. Another possible
reason for deviations from experimental studies performed on
other class C members can be related to the fact that the
simulations were performed including only the minimal
amount of ions required to neutralize the overall charge of
the system in the simulation box. In other words, the
physiological ionic strength was not explicitly taken into
account. While this is quite a popular simulative setup, it is
difficult to assess any possible implications of this choice in
quantitative estimates such as free-energy barriers.
Concerning the reliability of the mechanistic interpretation,
there are two aspects worth considering. The first one is
related to the quality of the reaction coordinate, namely, the S
variable. While the committor analysis revealed that the
location of the transition state ensemble was reasonable, we
note that the closet-to-open motion (or vice versa) was never
sampled through unbiased MD simulations and a suitable
procedure involving interpolation among cluster representa-
tives was necessary to reconstruct the whole transition. Even
though the usage of the Z variable lends nonlocality to
metadynamics sampling, we cannot exclude that other
competing routes might be involved in the domain motion.
Since the optimized path was solely derived by information
coming from prior unbiased MD simulations, these hypo-
thetical routes might be hidden to our PCV space simply
because of the limitation of sampling. This leads us to the
second topic, which is related to the accuracy of the
reconstructed free-energy profile by metadynamics. The
convergence of results is a long-standing issue of metady-
namics simulations. In this work, we used WT-MetaD that by
virtue of the decreasing heights of the Gaussians is expected to
converge the free energy to stationary values in the limit of
exhaustive sampling. Unfortunately, the system might become
trapped in some regions of the CVs space leading to an
undesired oversampling and resulting in an unbalanced
reconstruction of the FES. To avoid this behavior, it is a
common practice to stop the metadynamics simulation right
after the achievement of the main recrossing event. In this
work, the metadynamics simulation was carried out for a total
simulation time of 2 μs and the free energy reconstructed at 1.2
μs was considered to provide a faithful intepreteation of the
process under investigation. Even though the presented results
make us confident about the reliability of the relative energy
difference among the main basins, it is possible that much
longer (and possibly repeated) simulations would be required
to properly converge the free energy at the transition state
region.
■ CONCLUSIONS AND FUTURE PERSPECTIVES
In this study, we have investigated the dynamics of the
GABAB1b-R VFT in the absence of ligands by combining
unbiased molecular dynamics (MD) with path-metadynamics.
The results confirm that the relaxed open state and active
closed state are the two main conformational states of the
GABAB1b-R VFT. The two states are iso-energetic but
separated by a substantial energy barrier. This result, together
with the stable geometry of key residues in lobe 1 of the
orthosteric binding pocket, indicates that the GABAB1b-R VFT
will not oscillate between the two conformations in absence of
a ligand contrary to mGluRs. This also explains the consistency
of the crystal structures where all agonist- or antagonist-
complexed conformations are open or closed, respectively. In a
future perspective, a simulation using the dimer could also be
beneficial to investigate the role of GABAB2-R on ligand
binding, interface interactions and potentially the wide-open
state observed in this study.
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Bettler, B.; Balerio, G. N. Nicotine-Induced Molecular Alterations Are
Modulated by GABAB Receptor Activity: GABAB Receptors and
Nicotine. Addict. Biol. 2018, 23, 230−246.
(4) Fatemi, S. H.; Folsom, T. D.; Thuras, P. D. GABA A and GABA
B Receptor Dysregulation in Superior Frontal Cortex of Subjects with
Schizophrenia and Bipolar Disorder. Synapse 2017, 71, No. e21973.
(5) Chun, L.; Zhang, W.-h.; Liu, J.-f. Structure and Ligand
Recognition of Class C GPCRs. Acta Pharmacol. Sin. 2012, 33,
312−323.
(6) Kniazeff, J.; Galvez, T.; Labesse, G.; Pin, J.-P. No Ligand Binding
in the GB2 Subunit of the GABA B Receptor is Required for
Activation and Allosteric Interaction between the Subunits. J.
Neurosci. 2002, 22, 7352−7361.
(7) Binet, V.; Brajon, C.; Le Corre, L.; Acher, F.; Pin, J.-P.; Preźeau,
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